Slug is Overexpressed in Gastric Carcinomas and May Act Synergistically with SIP1 and Snail in the Down-regulation of E-cadherin
Affiliations
Epithelial-mesenchymal transition (EMT) involving down-regulation of E-cadherin is known to play an important role in tumour progression. The aim of our study was to investigate the mRNA expression of two EMT regulators-Slug and E12/E47-in primary human gastric carcinomas and to compare this with the expression of E-cadherin and other EMT regulators (Snail, Twist, and SIP1). We studied a series of 59 gastric carcinomas by real-time quantitative RT-PCR in formalin-fixed and paraffin-embedded tissues. Thirty-four cases (58%) showed Slug up-regulation in the tumour; reduced or negative expression of E-cadherin was present in 24 of these (71%, p<0.0001). Twenty-one cases (36%) showed E12/E47 up-regulation that was not significantly associated with E-cadherin down-regulation (p=0.5734). Slug up-regulation accompanied by E-cadherin down-regulation correlated with the presence of distant metastases (p=0.0029) and with advanced pTNM stages (p=0.0424). A statistically significant association was found between Slug up-regulation and the expression of SIP1 in intestinal (p=0.0014) and Snail in diffuse (p=0.0067) carcinomas. We present the first study integrating the analysis of several EMT regulators in primary gastric carcinomas and conclude that Slug up-regulation is associated with E-cadherin down-regulation in diffuse and intestinal-type gastric carcinoma, and that this effect could be complemented by the presence of other EMT regulators.
and epithelial mesenchymal transition in human gastric cancers: An update of the literature.
Jamal Eddin T, Nasr S, Gupta I, Zayed H, Moustafa A Heliyon. 2023; 9(8):e18945.
PMID: 37609398 PMC: 10440535. DOI: 10.1016/j.heliyon.2023.e18945.
Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential.
Liu S, Liu X, Lin X, Chen H Cells. 2023; 12(9).
PMID: 37174714 PMC: 10177130. DOI: 10.3390/cells12091314.
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3.
Lin Y, Zhan M, Xu B J Cancer Res Clin Oncol. 2023; 149(10):7663-7677.
PMID: 37000263 DOI: 10.1007/s00432-023-04705-2.
Wang L, Chen J, Zuo Q, Wu C, Yu T, Zheng P Oncogenesis. 2022; 11(1):29.
PMID: 35641480 PMC: 9156786. DOI: 10.1038/s41389-022-00405-7.
pSlug immunohistochemistry is a novel promising mitotic marker for FFPE samples: a pilot study.
Woo C, Son S, Lim Y, Lee D, Park J, Kim E Virchows Arch. 2021; 480(2):449-457.
PMID: 34510267 DOI: 10.1007/s00428-021-03201-7.